Articles By RheumNow
In Lupus, Keep BP Below 130/80
By RheumNow
Blood pressure should be maintained at a level below 130/80 mm Hg in all patients with lupus to lessen their likelihood of atherosclerotic vascular events, Canadian researchers asserted.
Read Article
In Vasculitis, Beware of Infection
By RheumNow
Risks of infection were strikingly high among patients with antineutrophil cytoplasmic antibody-associated (ANCA) vasculitis, which may relate to both the disease and its treatment, Scottish researchers found.
Read Article
Diabetes in OA: Pain Is Worse
By RheumNow
Among patients with knee osteoarthritis (OA), pain was greater for those with coexisting diabetes mellitus (DM), and this association was independent of obesity and radiographic severity, European researchers found.
Read Article
Don't Blame the Weather in Sjogren's
By RheumNow
Seasonal variations in symptoms -- commonly reported by patients with rheumatic diseases -- were not observed in a large cohort of patients with primary Sjogren's syndrome, French investigators found.
Read Article
Fatigue Looms Large in Lupus
By RheumNow
Fatigue is an important component of the disease experience in systemic lupus erythematosus (SLE), and can have a profound impact on patients' perception of well-being, Italian researchers reported.
Read Article
Seronegativity on the Rise in RA
By RheumNow
Although the overall incidence rates of rheumatoid arthritis (RA) have remained stable over recent decades, there has been a significant increase in seronegative cases, a retrospective study showed.
Read Article
Hypersensitivity Reactions and Gout Tx: Watch the Dose
By RheumNow
Both allopurinol and febuxostat (Uloric) were associated with an increased risk of hypersensitivity reactions among new users of these urate-lowering therapies, a large U.S. study found.
Read Article
Biosimilars for Rheum Disease: Failure to Launch
By RheumNow
The availability of biologic biosimilars has thus far had negligible impact on prescribing practices in the United States, in stark contrast to what has been observed in some European countries, researchers reported.
Read Article
Best of 2019 - Is Methotrexate Necessary with Tofacitinib?
By RheumNow
Rheumatoid arthritis patients taking tofacitinib (Xeljanz) plus methotrexate who achieved low disease activity (LDA) may be able to withdraw from the latter agent without significant worsening of disease activity, a researcher reported at EULAR 2019 in Madrid.
Read Article
A Role for SGLT2 Inhibition in Gout?
By RheumNow
The antidiabetic medication canagliflozin (Invokana) lowered serum urate and reduced the risk of gout flare in a post-hoc analysis of data from two large clinical trials.
Read Article